While both semaglutide and tirzepatide are effective in managing type 2 diabetes and offer weight loss benefits, they differ in their mechanisms of action (GLP-1 receptor agonist vs. dual GLP-1/GIP receptor agonist) and dosing regimens. The choice between these medications is often based on individual patient factors, including treatment goals, preferences, and response to therapy.
What is the difference between Semaglutide and Tirzepatide?
